See more : GlobalData Plc (DATA.L) Income Statement Analysis – Financial Results
Complete financial analysis of Sandu Pharmaceuticals Limited (SANDUPHQ.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Sandu Pharmaceuticals Limited, a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
You may be interested
- Far EasTone Telecommunications Co., Ltd. (4904.TW) Income Statement Analysis – Financial Results
- Catalent, Inc. (CTLT) Income Statement Analysis – Financial Results
- PT Bank Woori Saudara Indonesia 1906 Tbk (SDRA.JK) Income Statement Analysis – Financial Results
- Agile Content, S.A. (AGIL.MC) Income Statement Analysis – Financial Results
- Hercules Capital, Inc. (HCXY) Income Statement Analysis – Financial Results
Sandu Pharmaceuticals Limited (SANDUPHQ.BO)
About Sandu Pharmaceuticals Limited
Sandu Pharmaceuticals Ltd. engages in the manufacture and marketing of Ayurvedic medicines. It offers its products under the Berbenteron suspension, Berbenteron tablets, Bilagyl, Debix, Elegance Oil, Ephenin, Haemol Forte, Madiphal Rasayan, Osteon D, Pregutero, Sarak, Shatari, Stresan, Jaundex, Vanari Kalpa, Vimfix, Whoopin and Pentazyme brands. The company was founded on May 10, 1899 and is headquartered in Mumbai, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 672.81M | 653.49M | 655.01M | 587.45M | 483.67M | 494.25M | 490.16M | 428.25M | 410.78M | 396.02M | 359.61M | 301.89M | 312.45M | 215.87M | 155.69M | 142.58M | 134.70M |
| Cost of Revenue | 442.78M | 322.57M | 357.43M | 356.58M | 259.81M | 260.34M | 283.94M | 256.37M | 212.87M | 220.24M | 212.05M | 173.31M | 157.66M | 59.16M | 48.18M | 31.55M | 29.91M |
| Gross Profit | 230.03M | 330.92M | 297.58M | 230.87M | 223.87M | 233.91M | 206.22M | 171.89M | 197.92M | 175.77M | 147.56M | 128.59M | 154.78M | 156.71M | 107.52M | 111.04M | 104.78M |
| Gross Profit Ratio | 34.19% | 50.64% | 45.43% | 39.30% | 46.28% | 47.33% | 42.07% | 40.14% | 48.18% | 44.39% | 41.03% | 42.59% | 49.54% | 72.59% | 69.06% | 77.88% | 77.79% |
| Research & Development | 1.08M | 1.25M | 1.61M | 1.41M | 1.26M | 339.82K | 303.41K | 130.32K | 114.13K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 9.75M | 9.07M | 9.99M | 7.52M | 7.85M | 7.82M | 9.81M | 6.69M | 854.68K | 0.00 | 0.00 | 0.00 | 0.00 | 8.14M | 6.42M | 0.00 | 0.00 |
| Selling & Marketing | 117.12M | 97.13M | 85.14M | 68.98M | 71.97M | 83.27M | 58.77M | 44.22M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 113.69M | 81.09M | 0.00 | 0.00 |
| SG&A | 126.87M | 106.20M | 95.13M | 76.50M | 79.83M | 91.10M | 68.58M | 50.91M | 854.68K | 0.00 | 0.00 | 0.00 | 0.00 | 121.82M | 87.51M | 0.00 | 0.00 |
| Other Expenses | 84.96M | 3.27M | 828.00K | 100.00 | 4.53M | -586.52K | -1.57M | 25.21K | 190.08K | 162.91K | 2.04M | 1.08M | 939.65K | 616.16K | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 212.90M | 311.23M | 274.14M | 214.85M | 214.06M | 218.18M | 187.12M | 160.84M | 175.53M | 157.15M | 132.04M | 113.07M | 140.77M | 144.03M | 95.55M | 98.19M | 93.45M |
| Cost & Expenses | 655.68M | 633.80M | 631.57M | 571.42M | 473.87M | 478.51M | 471.06M | 417.20M | 388.39M | 377.40M | 344.09M | 286.37M | 298.44M | 203.19M | 143.73M | 129.73M | 123.37M |
| Interest Income | 1.59M | 1.58M | 763.00K | 1.89M | 3.71M | 4.56M | 233.10K | 3.47M | 348.71K | 792.43K | 700.95K | 966.30K | 1.22M | 891.44K | 46.12K | 0.00 | 0.00 |
| Interest Expense | 631.00K | 721.00K | 1.10M | 647.00K | 4.05M | 9.36M | 11.77M | 14.46M | 15.73M | 13.22M | 10.11M | 5.57M | 4.88M | 3.43M | 3.44M | 3.80M | 3.34M |
| Depreciation & Amortization | 5.83M | 5.17M | 5.30M | 5.57M | 5.52M | 6.36M | 6.02M | 8.68M | 6.93M | 10.52M | 5.36M | 4.35M | 4.34M | 3.74M | 3.61M | 3.20M | 3.10M |
| EBITDA | 27.19M | 28.13M | 29.16M | 23.17M | 19.06M | 26.65M | 25.89M | 24.15M | 29.46M | 30.03M | 24.02M | 19.87M | 18.35M | 17.77M | 15.58M | 16.05M | 14.44M |
| EBITDA Ratio | 4.04% | 4.29% | 4.51% | 3.92% | 3.88% | 5.24% | 5.07% | 5.31% | 7.24% | 7.58% | 6.59% | 6.58% | 5.87% | 8.23% | 10.01% | 11.26% | 10.72% |
| Operating Income | 17.13M | 19.69M | 23.46M | 15.92M | 9.05M | 14.93M | 18.74M | 9.19M | 6.60M | 6.12M | 6.19M | 10.57M | 10.25M | 9.98M | 8.70M | 9.05M | 7.99M |
| Operating Income Ratio | 2.55% | 3.01% | 3.58% | 2.71% | 1.87% | 3.02% | 3.82% | 2.15% | 1.61% | 1.55% | 1.72% | 3.50% | 3.28% | 4.62% | 5.59% | 6.35% | 5.93% |
| Total Other Income/Expenses | 3.60M | 2.48M | -291.00K | 893.44K | -619.08K | -5.56M | -11.55M | -8.66M | -15.00M | 162.91K | 2.04M | 1.08M | 939.65K | -2.37M | -3.26M | -3.73M | 0.00 |
| Income Before Tax | 20.73M | 22.17M | 23.17M | 16.81M | 9.19M | 10.18M | 7.55M | 533.27K | 6.79M | 6.29M | 8.23M | 11.64M | 11.19M | 10.59M | 8.70M | 9.05M | 7.99M |
| Income Before Tax Ratio | 3.08% | 3.39% | 3.54% | 2.86% | 1.90% | 2.06% | 1.54% | 0.12% | 1.65% | 1.59% | 2.29% | 3.86% | 3.58% | 4.91% | 5.59% | 6.35% | 5.93% |
| Income Tax Expense | 6.12M | 6.96M | 7.27M | 5.88M | 1.99M | 3.49M | 1.94M | 4.98M | 1.42M | 2.15M | 3.27M | 3.84M | 6.36M | 2.44M | 1.74M | 420.00K | 506.00K |
| Net Income | 14.61M | 15.20M | 15.90M | 10.93M | 7.20M | 6.69M | 5.62M | -4.44M | 5.38M | 4.14M | 4.96M | 7.80M | 4.84M | 8.16M | 7.01M | 8.63M | 7.49M |
| Net Income Ratio | 2.17% | 2.33% | 2.43% | 1.86% | 1.49% | 1.35% | 1.15% | -1.04% | 1.31% | 1.04% | 1.38% | 2.58% | 1.55% | 3.78% | 4.50% | 6.05% | 5.56% |
| EPS | 1.51 | 1.61 | 1.99 | 1.54 | 1.02 | 0.94 | 0.79 | -0.63 | 0.76 | 0.58 | 0.70 | 1.10 | 0.68 | 1.15 | 0.99 | 1.22 | 1.06 |
| EPS Diluted | 1.51 | 1.61 | 1.87 | 1.54 | 1.02 | 0.94 | 0.79 | -0.63 | 0.76 | 0.58 | 0.70 | 1.10 | 0.68 | 1.15 | 0.99 | 1.22 | 1.06 |
| Weighted Avg Shares Out | 9.68M | 9.43M | 8.00M | 7.08M | 7.08M | 7.08M | 7.08M | 7.08M | 7.08M | 7.08M | 7.08M | 7.08M | 7.08M | 7.08M | 7.08M | 7.07M | 7.06M |
| Weighted Avg Shares Out (Dil) | 9.68M | 9.43M | 8.50M | 7.09M | 7.08M | 7.08M | 7.08M | 7.08M | 7.08M | 7.08M | 7.08M | 7.08M | 7.08M | 7.08M | 7.08M | 7.07M | 7.06M |
No news found for: SANDUPHQ.BO
Source: https://incomestatements.info
Category: Stock Reports